the Immediate and Long-lasting Effects of the X10D Sole on Important Aspects of Walking Function in Healthy ParticipantsNCT07296913
Studying the Effects of the X10D Shoe on Walking in Healthy Adults Aged 50 to 65
A study testing X10D shoe in people with the Immediate and Long-lasting Effects of the X10D Sole on Important Aspects of Walking Function in Healthy Participants and Walking, run by University of Zurich at 1 site in Switzerland.
Trial summary
The aim of this study is to characterize the biomechanical effects of the X10D sole using objective, quantitative measurement methods. The walking pattern of many people is becoming increasingly passive, and the muscles of the feet and legs are getting weaker. Read more about this study
- Who is it for?
- Ages 50 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- the Immediate and Long-lasting Effects of the X10D Sole on Important Aspects of Walking Function in Healthy Participants, Walking
- What is being tested?
- X10D shoe
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 15 participants
- Where
- 1 siteSwitzerland
- Study dates
- 3 Oct 2025to 19 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- The inclusion criteria are:
- Healthy subjects aged 50-65 years
- Ability to walk at minimum 30 minutes at a regular pace without assistance or breaks
- Written informed consent as documented by signature (see informed consent form)
Who cannot join
- Women who are pregnant or breast feeding
- Current neurological problems affecting walking function and balance
- Current orthopedic problems affecting upper and lower extremity movements
- History of alcohol abuse or the intake of psychotropic drugs
- History of major cardiac condition (e.g., infarction, insufficiency (NYHA II-IV))
- History of major pulmonary condition (e.g., chronic obstructive pulmonary disease (GOLD II-IV))
Show all 9Show fewer
- Current major depression or psychosis
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia
- Fever of unknown origin
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Characterizing the Effects of the X10D Sole on Walking Behavior in Healthy Subjects
The aim of this study is to characterize the biomechanical effects of the X10D sole using objective, quantitative measurement methods.
The walking pattern of many people is becoming increasingly passive, and the muscles of the feet and legs are getting weaker. The X10D shoe is an adapted shoe designed to make walking more active and dynamic again.
This study investigates the detailed biomechanical effects of the X10D shoe on the walking pattern of healthy participants. For this purpose, walking with the X10D shoe will be compared with (1) walking in a control shoe with a neutral sole and (2) walking in the participants' everyday sports shoes.
- Conditions
- the Immediate and Long-lasting Effects of the X10D Sole on Important Aspects of Walking Function in Healthy Participants, Walking
- Being tested
- X10D shoe
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
X10D shoeDevice
In this study, we assess the immediate and long-lasting (3-4 weeks) effects of the X10D shoe on a comprehensive battery of biomechanical parameters during various forms of walking. This will be the first study to provide a detailed characterization of the effects of the X10D shoe on diverse walking parameters in healthy individuals aged 50 to 65 years.
| Study group | Role | What they receive |
|---|---|---|
| Interventional shoe | Experimental | Not described Receives: Device: X10D shoe |
What is being measured
The primary outcome is the main question the study is designed to answer.
CoP path during ankle-foot roll-over movement as measured by pressure plates integrated in the treadmill
Measured: up to 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Dec 2025
- Study start3 Oct 2025
- Primary completion19 Dec 2025
- Study completion19 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for the Immediate and Long-lasting Effects of the X10D Sole on Important Aspects of Walking Function in Healthy ParticipantsStudies of the same condition, open and under way.
- More trials run by University of ZurichThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 15 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Zurich
- Sponsor type
- University, hospital or other
- Collaborators
- Balgrist Campus AG
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07296913
- Sponsor's protocol ID
- 2025-00477
- Other IDs
- 2025
- Status last verified
- Jan 2026
- First submitted
- 27 Nov 2025
- Last updated
- 16 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Characterizing the Effects of the X10D Sole on Walking Behavior in Healthy Subjects
- ClinicalTrials.gov ID
- NCT07296913
- Acronym / sponsor ID
- 2025-00477
- Conditions
- the Immediate and Long-lasting Effects of the X10D Sole on Important Aspects of Walking Function in Healthy Participants, Walking
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 15 participants (actual)
- Lead sponsor
- University of ZurichUniversity, hospital or other
- Collaborators
- Balgrist Campus AG
- Study start
- 3 Oct 2025 (actual)
- Primary completion
- 19 Dec 2025 (actual)
- Study completion
- 19 Dec 2025 (actual)
- First posted
- 22 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to characterize the biomechanical effects of the X10D sole using objective, quantitative measurement methods.
The walking pattern of many people is becoming increasingly passive, and the muscles of the feet and legs are getting weaker. The X10D shoe is an adapted shoe designed to make walking more active and dynamic again.
This study investigates the detailed biomechanical effects of the X10D shoe on the walking pattern of healthy participants. For this purpose, walking with the X10D shoe will be compared with (1) walking in a control shoe with a neutral sole and (2) walking in the participants' everyday sports shoes.
Study design
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Interventional shoe | Experimental | Device: X10D shoe |
Who may qualify
- Ages
- 50 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Healthy subjects aged 50-65 years
- Ability to walk at minimum 30 minutes at a regular pace without assistance or breaks
- Written informed consent as documented by signature (see informed consent form)
Key exclusion criteria (9 listed)
- Women who are pregnant or breast feeding
- Current neurological problems affecting walking function and balance
- Current orthopedic problems affecting upper and lower extremity movements
- History of alcohol abuse or the intake of psychotropic drugs
- History of major cardiac condition (e.g., infarction, insufficiency (NYHA II-IV))
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| X10D shoeIn this study, we assess the immediate and long-lasting (3-4 weeks) effects of the X10D shoe on a comprehensive battery of biomechanical parameters during various forms of walking. This will be the first study to provide a detailed characterization of the effects of the X10D shoe on diverse walking parameters in healthy individuals aged 50 to 65 years. | Device | Interventional shoe |
Primary outcome
CoP path during ankle-foot roll-over movement as measured by pressure plates integrated in the treadmill
Time frame: up to 4 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jan 2026.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing X10D shoe in people with the Immediate and Long-lasting Effects of the X10D Sole on Important Aspects of Walking Function in Healthy Participants and Walking, run by University of Zurich at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
CoP path during ankle-foot roll-over movement as measured by pressure plates integrated in the treadmill (time frame: up to 4 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2026.